News

Designed to optimize yield in both R&D and cGMP applications, the autoclavable bioreactors are compatible with Finesse G3Lab controllers, and SmartAdapters and can be used with third party

Designed to offer up to three days of pain relief following surgery, Posidur uses the company’s patented SABER technology to deliver bupivacaine. DURECT president and CEO James Brown

The patent covers the method of treating human diseases or disorders using PI3K and HDAC proteins, including but not restricted to CUDC-907. Designed to inhibit PI3K-alpha, delta and

The single ascending dose study will assess the safety, tolerability, pharmacokinetic and pharmacodynamic profile of BGB324. BerGenBio CEO Richard Godfrey said the Phase 1 trial of BGB324 will

PrioClear is incorporated into Octapharma’s manufacturing process for its solvent/detergent treated plasma product, Octaplas, which is currently approved for marketing in US and several European countries. The order

The new product is designed to reduce the formation of advanced glycation end-products (AGEs) associated with normal metabolism and aging. AGEs are the result of a common enzymatic

The Kurma Biofund II fund is led by Paris-based venture capital firm Kurma Life Science Partners (KLS) and is supported by other investors namely, CDC Entreprises, Idinvest Partners

As per the plan, the project could result in elimination of up to 55 jobs to reduce costs and align more than 30 affiliates in 10 strong business

The research facility includes 30-bed, Phase 1 unit and multiple outpatient clinical examination rooms. As part of the company’s Research Clinics Division, the new facility is also used